Abstract

Background and Aims : Patients with type 2 diabetes mellitus (T2DM) and atherogenic dyslipidaemia (AD) are at higher risk of developing cardiovascular diseases (CVDs) so interest in discovering inflammation biomarkers as indicators of processes related to CVD progression is increasing. This study aims to characterize the plasma glycoprotein profile of a cohort of 504 participants including patients with and without T2DM and/or AD and controls.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call